The Inside Scoop on Canbiola Inc (CANB)

0

Canbiola Inc (CANB) saw a pop  last week after the Company announced they purchased Pure Health Products LLC and is launching Pure Leaf Oil as its consumer brand. Canbiola, Inc. has recently completed the acquisition of Pure Health Products LLC including the laboratory and production facility located outside Seattle Washington.  The facility is a full-on development laboratory and a fully integrated production facility whereby all formulations, processes, and materials are vertically integrated in the production process.  There are no third-party vendors and the company controls the process at each step of processing to insure 100% quality control and product purity.  Additionally, all the automated processing and packaging equipment are wholly owned, and the company has no debt.

CANB has a long history of explosive moves running from $0.01 to highs of $0.135 in September during the heat of the pot stock boom before cooling off in October with the rest of the sector.  Investors are looking for a pop back over a dime where it was at in December.

Canbiola Inc (CANB) is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states.

CANB says they are on a path toward significant revenue growth in additional segments of the CBD industry.  While the Canbiola brand is synonymous with Medical Offices and our Doctor affiliate program, the company has launched Pure Leaf Oil targeting retail markets including c-stores, bodegas, and yes, even donut stores and bakeries through its network of distributors. Pure Leaf Oil is also expected to be sold through various leading online e-commerce platforms at very aggressive prices.

CANB also owns two technological solutions, Wrapmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker-dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance. In May 2017 the Company changed their name from Wrapmail, Inc. to Canbiola Inc.

To Find out the inside Scoop on CANB Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Canbiola, Inc. has already launched a number of products that are available on their corporate website such as Cannabidiol (CBD) based oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is committed to providing the highest quality and lowest cost hemp solutions with the highest purity standards in the industry. CANB product offerings have been very popular so far and have resulted in fact growing revenues for the Company. According to their 10Q from November 14, CANB reported product sales of $163,328 for the 3 months ended September 30, compared to just $22k in 2017.

In December CANB announced it has made significant investment in development of its nationwide distribution infrastructure through Its doctor and medical office network and expects this forward movement to continue.  This trend is even potentially more impactful with President Trump signing of the 2018 Farm Bill.   The 2018 Farm Bill removed CBD derived hemp from the Schedule 1 drug list and makes hemp CBD Federally legal for use, interstate transporting, and export.   Hemp based CBD with under .3% THC (the psychoactive ingredient in marijuana) has proven to be medically beneficial in a regimen of wellness and pain relief programs.

CANB CEO Marco Alfonsi said of their latest acquisition:

“We believe the timing is right for the roll-out of the new Pure Leaf Oil CBD brands and have already aligned with some substantial distributors representing thousands of retail stores to commence distribution.”   Mr. Alfonsi continued, “The new Pure Leaf Oil products will mirror the Canbiola product line offering in product strength and efficacy and provide better access to patients seeking over-the-counter pain relief and wellness products containing CBD with none of the marijuana THC psychoactive side effects.”  Lastly, Mr. Alfonsi added, “To have a seasoned professional as Mr. Pasquale (Pat) Ferro head up the Pure Health Products subsidiary as President speaks to the quality of the entire Canbiola staff and professional team.  Pat is a friend, a strong manager with a proven track record, and is heading up the future product development efforts for the company.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $22.7 million market valuation CANB has little debt, $380k in the treasury and growing sales reporting $163,328 in revenues for the 3 months ended September 30, 2018. Canbiola is on the path toward significant revenue growth in additional segments of the CBD industry.  While the Canbiola brand is synonymous with Medical Offices and our Doctor affiliate program, the company has launched Pure Leaf Oil targeting retail markets including c-stores, bodegas, and yes, even donut stores and bakeries through its network of distributors. We will be updating on CANB when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CANB.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.

Disclosure: we hold no position in CANB either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.